Dysregulation of SOX17/NRF2 axis confers chemoradiotherapy resistance and emerges as a novel therapeutic target in esophageal squamous cell carcinoma

BACKGROUND: Esophageal squamous cell carcinoma (ESCC) is the sixth leading cause of cancer-associated death worldwide with a dismal overall 5-year survival rate of less than 20%. The standard first-line therapy for advanced ESCC is concomitant chemo-radiation therapy (CCRT); however, patients usuall...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsieh, Chih-Hsiung, Kuan, Wen-Hui, Chang, Wei-Lun, Kuo, I-Ying, Liu, Hsun, Shieh, Dar-Bin, Liu, Hsuan, Tan, Bertrand, Wang, Yi-Ching
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618214/
https://www.ncbi.nlm.nih.gov/pubmed/36310172
http://dx.doi.org/10.1186/s12929-022-00873-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618214/
https://www.ncbi.nlm.nih.gov/pubmed/36310172
http://dx.doi.org/10.1186/s12929-022-00873-4

Ejemplares similares